Loading data for DCTH — first visit, this takes a few seconds.
Delcath Systems Inc. (DCTH)
NasdaqCM: DCTH
· リアルタイム株価 · USD
17.09
+0.34 (2.03%)
終値時点: Aug 25, 2026, 1:50 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Delcath Systems Inc.(DCTH)の株価・分析・データ
2.03% (1D)
DCTHについて
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial fo...
企業情報の全文

